Analyst Joseph Pantginis of H.C. Wainwright maintained a Buy rating on Palatin Technologies (PTN – Research Report), retaining the price ...

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

Introduction: Brain natriuretic peptide (BNP) is commonly used for the diagnosis and management of heart failure (HF), as its presence strongly predicts cardiovascular events and risk of death.

Palatin Technologies (PTN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph ...

Atrial natriuretic peptide (ANP) was the first natriuretic ... in the atria of the heart and activated when the atrial stretch receptors become stimulated in response to hypervolemia, increased ...

"Cardiomyopathy" is an umbrella term for diseases of the heart muscle that negatively impact its structure and ...

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic ...

Medically reviewed by Christopher Lee, MD Systolic congestive heart failure, or systolic heart failure, is a type of heart ...

Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Serum uric acid (SUA), a product of ...

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight ...

Glucagon-like peptide-1 (GLP-1) receptor agonists, which can slow gastric emptying and increase the risk of retained gastric contents, are increasingly prescribed for ...